Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Villin-1 in Pomacea canaliculata is an actin-binding protein belonging to the gelsolin superfamily, primarily involved in the organization and maintenance of the microvilli in the intestinal brush border (UniProt, 2024). It functions by bundling, capping, and severing actin filaments in a calcium-dependent manner, which is crucial for the structural integrity and absorptive capacity of the snail's digestive tract (PubMed, 29539642). While villin is a well-characterized protein in vertebrates, its specific role in the golden apple snail—a notorious invasive species and agricultural pest—is studied primarily in the context of snail physiology and its ability to host human parasites like Angiostrongylus cantonensis (NCBI, 2023). There are currently no known therapeutic drugs targeting Pomacea canaliculata villin for human use, nor is it a standard target for molluscicides, which typically target metabolic or neurological pathways. In human medicine, villin-1 is used as a diagnostic biomarker for neuroendocrine tumors and colorectal carcinomas, but the snail ortholog is not utilized in clinical practice (StatPearls, 2023). Research into this specific protein is limited compared to its mammalian counterparts, focusing mainly on its structural contribution to the snail's gut (PubMed, 29539642). Consequently, it does not currently serve as a target for drug development or therapeutic intervention.
Not applicable as there are no known drugs targeting this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Villin-1 (Pomacea canaliculata) (Vil1).